Meijerink Hinta, Indrati Agnes R, van Crevel Reinout, Joosten Irma, Koenen Hans, van der Ven Andre J A M
Department of Internal Medicine, Radboud University Medical Center, Route 456, PO Box 910, 6500 HB, Nijmegen, The Netherlands.
Health Research Unit, Faculty of Medicine, Universitas Padjadjaran/Hasan Sadikin Hospital, Bandung, Indonesia.
BMC Infect Dis. 2014 Dec 13;14:683. doi: 10.1186/s12879-014-0683-0.
The HIV co-receptors CXCR4 and CCR5 play an important role in HIV infection and replication. Therefore we hypothesize that long-term non-progressors (LTNP) with viral control have lower expression of CCR5 and CXCR4 on CD4(+) cells, specifically on memory T-lymphocytes since they are the primary target cells of HIV.
In this cross-sectional study, we included five HIV-infected LTNP with viral control (CD4 > 750 cell/μl & HIV < 50 copies for ≥2 years), thirteen HIV-infected and seven HIV-uninfected individuals at Radboud UMC Nijmegen, the Netherlands. We determined the CCR5 and CXCR4 expression among CD4(+) and CD8(+) lymphocyte subsets; memory (CD45RO(+)), naïve (CD45RA(+)) cells and regulatory T-cells (CD4(+)CD25(high)FoxP3(+)). In addition, CCR5∆32 polymorphism is related with disease progression and was therefore determined using polymerase chain reaction.
The percentage of CCR5-expressing CD4(+) cells of LTNP was comparable with healthy controls; whereas HIV-infected individuals showed more CCR5-expressing cells. This was observed in memory and naïve CD4(+) cells, but not in regulatory T-cells. The mean fluorescence intensity of CCR5-expressing CD4(+) cells was similar in all groups. All groups had comparable percentages of CXCR4-expressing cells. The mean fluorescence intensity of CXCR4-expressing cells was significantly higher in HIV-infected normally progressors in both memory and naïve CD4(+) cells, but not in CD8(+) cells. The CCR5∆32 polymorphism was not related to group.
We show that HIV affects -directly or indirectly- the expression of CCR5 in CD4(+) T-lymphocytes; yet this effect is not seen in LTNP with viral control. Avoiding upregulation of CCR5 could be an important method via which LTNP counteracts the effects of HIV and suppresses viral replication. Exploring how LTNP suppress the upregulation of CCR5 could be an important step for discovering new therapeutics.
HIV共受体CXCR4和CCR5在HIV感染和复制中起重要作用。因此我们推测,病毒得到控制的长期不进展者(LTNP)的CD4(+)细胞,特别是记忆性T淋巴细胞(因为它们是HIV的主要靶细胞)上CCR5和CXCR4的表达较低。
在这项横断面研究中,我们纳入了荷兰奈梅亨拉德堡大学医学中心的5名病毒得到控制的HIV感染LTNP(CD4>750个细胞/μl且HIV<50拷贝,持续≥2年)、13名HIV感染个体和7名未感染HIV的个体。我们测定了CD4(+)和CD8(+)淋巴细胞亚群;记忆性(CD45RO(+))、初始(CD45RA(+))细胞和调节性T细胞(CD4(+)CD25(高)FoxP3(+))中CCR5和CXCR4的表达。此外,CCR5∆32多态性与疾病进展相关,因此使用聚合酶链反应进行测定。
LTNP中表达CCR5的CD4(+)细胞百分比与健康对照相当;而HIV感染个体显示出更多表达CCR5的细胞。在记忆性和初始CD4(+)细胞中观察到这种情况,但在调节性T细胞中未观察到。所有组中表达CCR5的CD4(+)细胞的平均荧光强度相似。所有组中表达CXCR4的细胞百分比相当。在记忆性和初始CD4(+)细胞中,HIV感染的正常进展者中表达CXCR4的细胞的平均荧光强度显著更高,但在CD8(+)细胞中并非如此。CCR5∆32多态性与分组无关。
我们表明,HIV直接或间接影响CD4(+)T淋巴细胞中CCR5的表达;然而,在病毒得到控制的LTNP中未观察到这种影响。避免CCR5上调可能是LTNP对抗HIV影响并抑制病毒复制的重要方法。探索LTNP如何抑制CCR5上调可能是发现新疗法的重要一步。